Brazil on the verge of ambitious re-use regulation update
This article was originally published in Clinica
Brazil is awaiting final approval of an ambitious update of its two-decade-old regulations on the reuse and reprocessing of medical devices and equipment. A resolution developed by the national healthcare surveillance agency, Anvisa, sets out 84 groups of products that would be declared single-use, while reprocessing and re-use would be subject to far stricter controls. The new law will affect the registration, labelling and reprocessing of medical devices.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.